London Business News | Londonlovesbusiness.com
2 days agoNovo Nordisk Q1 results: 'Strong performance' and 'rosy outlook' expected
Investment in Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic led to record growth in Q4 2023. [ more ]